No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors
byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma
Updated on: January 29,2024
No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors
byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma
Updated on:January 29,2024
